CLINICAL LABS & IMMUNODIAGNOSTICS

Shaping the future of diabetes, together

We are shaping the future of diabetes care with innovative technology to empower clinicians to make better treatment decisions and improve the quality of life for diabetes patients of all ages.
We are shaping the future of diabetes care with innovative technology to empower clinicians to make better treatment decisions and improve the quality of life for diabetes patients of all ages.

Boosting your lab’s productivity and efficiency

Diabetes is relentless. At the current growth rate, diabetes threatens to overwhelm global health care systems in the future. The need for innovation and leadership in the prevention and management of diabetes has never been more important.

Our comprehensive diabetes menu offers outstanding quality and accuracy enabling your lab to do more with less and clinicians to make better treatment decisions to improve the patient care.

Our new VITROS® A1c Solution is revolutionizing how your lab can help clinicians treat patients.

Diabetes Assay Menu

VITROS® Menu of Assays by Disease State (PDF)

ß-hydroxybuturate*

VITROS® 7600 Integrated System

VITROS® 5600 Integrated System

VITROS® 4600 Integrated System

BUN/Urea 

VITROS® 7600 Integrated System

VITROS® 5600 Integrated System

VITROS® 4600 Integrated System

VITROS® XT 3400 Integrated System

C-Peptide

VITROS® 7600 Integrated System

VITROS® 5600 Integrated System

VITROS® 3600 Immunodiagnostic System

VITROS® ECI/ECiQ Immunodiagnostic System

Creatinine

VITROS® 7600 Integrated System

VITROS® 5600 Integrated System

VITROS® 4600 Integrated System

VITROS® XT 3400 Integrated System

Glucose

VITROS® 7600 Integrated System

VITROS® 5600 Integrated System

VITROS® 4600 Integrated System

VITROS® XT 3400 Integrated System

Glycated Serum Protein*

VITROS® 7600 Integrated System

VITROS® 5600 Integrated System

VITROS® 4600 Integrated System

HbA1c

VITROS® 7600 Integrated System

VITROS® 5600 Integrated System

VITROS® 4600 Integrated System

A1c (D)

VITROS® 7600 Integrated System

VITROS® 5600 Integrated System

VITROS® 4600 Integrated System

VITROS® XT 3400 Integrated System

Insulin

VITROS® 7600 Integrated System

VITROS® 5600 Integrated System

VITROS® 3600 Immunodiagnostic System

VITROS® ECI/ECiQ Immunodiagnostic System

Microalbumin

VITROS® 7600 Integrated System

VITROS® 5600 Integrated System

VITROS® 4600 Integrated System

The VITROS® System
  • VITROS® 7600 Integrated System

  • VITROS® 5600 Integrated System

  • VITROS® 3600 Immunodiagnostic System

  • VITROS® ECI/ECiQ Immunodiagnostic System

  • VITROS® 4600 Integrated System

  • VITROS® XT 3400 Integrated System

  • *MicroTip Partnership Assay (MPA); Reagents and validated applications available directly from Ortho Clinical Diagnostics
  • D = In development/currently not available
  • § For Criminal Justice and Forensic use only

Boost your lab’s productivity and efficiency with our VITROS® Diabetes Menu

fh-icons
Excellent accuracy

Traceable to standardized materials and good correlation with other commercial assays

fh-icons
Long on-analyzer stability

Optimizes reagent use and decreases waste

fh-icons
Long calibration stability

Decreases the number of calibration events

fh-icons
Single-use tips and tests

No cuvettes to wash, no probes to clean, no risk of sample nor reagent carry-over

fh-icons
Highly specific detection

Highly specific antibodies and chemistry detection methods

fh-icons
Minimal interferences

None-to-minimal cross-reactivity and minimal interferences

VITROS A1c Solution: A breakthrough design in whole blood testing

Break free from the complexities of whole blood A1c testing with our novel enzymatic VITROS® A1c Slides and enhanced VITROS® Enabling Technologies so that you can report A1c results confidently, while increasing productivity and efficiency.

Its multi-layer Dry Slide design delivers exceptional performance that is certified by the National Glycohemoglobin Standardization Program (NGSP) and is free from hemoglobin variant interference* to bring you result peace of mind.

*Up to HbS ≤ 41%, HbC ≤ 36%, HbD ≤ 41%, HbE ≤ 40%

ih-half-img

Break free from your A1c workflow

Integrate your A1c testing so that you can do more with less hands-on time

Simplified Whole Blood Management

  • Less hands-on time
  • No separate pre-treatment step to lyse red blood cells
  • Direct primary tube sampling
  • Extended walkaway time up to 20 minute1

Exceptional Performance with No Hemoglobin Variant Interference2

  • Certified by NGSP2
  • Highly specific enzyme for exceptional performance
  • No interference from common hemoglobin variants3
  • Reliable performance with good precision
  • Standardized performance to Tosoh G8
  • No reagent nor sample carry-over with single-use disposable tips – no probes, tubes, cuvettes to wash

Integrated Workflow with Random Access Testing

  • Increase testing capacity in VITROS® MicroSlide format
  • Test A1c in-between other routine tests
  • Free up labor with VITROS® Automation Solutions track
  • Less hands-on time
  • No separate pre-treatment step to lyse red blood cells
  • Direct primary tube sampling
  • Extended walkaway time up to 20 minute1
  • Certified by NGSP2
  • Highly specific enzyme for exceptional performance
  • No interference from common hemoglobin variants3
  • Reliable performance with good precision
  • Standardized performance to Tosoh G8
  • No reagent nor sample carry-over with single-use disposable tips – no probes, tubes, cuvettes to wash
  • Increase testing capacity in VITROS® MicroSlide format
  • Test A1c in-between other routine tests
  • Free up labor with VITROS® Automation Solutions track

1. D48434 Whole Blood MicroSlide Processing Theory Guide

2. Up to HbS ≤ 41%, HbC ≤ 36%, HbD ≤ 41%, HbE ≤ 40%, HbA2 ≤ 7%, HbF ≤ 15%

3. National Glycohemoglobin Standardization Program. Certified Methods. http://www.ngsp.org/certified.asp  

Innovative MicroSlide design

Our VITROS® MicroSlide Technology uses a dry multi-layer, integrated testing environment to optimize each processing step for excellent accuracy and precision.

  • Excellent performance stability
  • Application of sample activates the dry slide reagent
  • Unique spread layer traps endogenous interferents (HIT, drugs, paraproteins, etc.)
  • Small sample sizes ideal for precious, hard-to-draw patients (2.7 -11.0 µL)

Insulin

VITROS® Immunodiagnostic Products Insulin Reagent

The VITROS Insulin assay has excellent performance to help clinicians understand the cause of a patient’s hypoglycemia or differentiate between type I and type II diabetes. Measuring insulin levels can evaluate the production and resistance.

The VITROS Insulin assay antibody is highly specific for insulin detection, with no cross-reactivity to C-peptide or Proinsulin.* Importantly it has insignificant or no cross-reactivity to insulin analogs commonly used in diabetes treatment.
*Ding, Qian. Performance Comparison of VITROS Immunodiagnostic Products Insulin Assay. Ortho Clinical Diagnostics PR-03149. 2017

C-Peptide

VITROS Immunodiagnostics C-Peptide Assay

C-peptide testing provides a reliable assessment of beta-cell function and aids in differentiating Type I, Type II diabetes and MODY. Differentiating the diabetes type at clinical presentation is challenging and treatment decisions can improve with clear answers.

The VITROS C-Peptide assay uses an antibody highly specific for C-Peptide detection with no significant cross-reactivities to insulin, proinsulin, glucagon, calcitonin or somatostatin.

β-Hydroxybutyrate LiquiColor® Assay*

When seconds count in the ED, confidence is everything

Diabetic Ketoacidosis (DKA) can manifest as the first sign of diabetes for patients with type 1 and can occur in severe cases of hyperglycemia for patients with type 2 diabetes.

The ß-Hydroxybutyrate LiquiColor® Assay* quantitatively measures ß-Hydroxybutyrate (BHB), the major ketone by product from the body metabolizing stored fat in the liver when glucose is not available. The buildup of ketones in the blood can be fatal if left unchecked.

The ß-Hydroxybutyrate LiquiColor® Assay* is highly specific and is not susceptible to interferences for excellent performance on VITROS Systems. This lifesaving test is ready when you are.

*MicroTip Partnership Assay. May not be available in all countries.

Glycated Serum Protein Assay*

Glycemic monitoring for patients of all life stages

Health conditions that alter the red blood cell lifespan are not suitable candidates for traditional HbA1c testing methods. Monitoring glycated serum proteins (GSP) provides clinicians with a short-term glycemic view of two to three weeks that can be used with these conditions and can useful in monitoring the effects of changes in diabetes treatment.

The Glycated Serum Protein Assay uses an enzyme that is highly specific to glycated serum proteins. It does not have interference to reducing substances such as vitamins and bilirubins, unlike older colorimetric fructosamine assays.

Please contact Ortho Care® Services at Fill phone # in by Region to learn how to gain access to specific technical information by registering on the Diazyme Laboratories Inc. website.

*MicroTip Partnership Assay. May not be available in all countries.

Comprehensive Care

VIPLabTech

Service & Support

Imagine going from clutter to clarity and having seamless control of your lab. Our Ortho Care® Services and Informatics gives you the freedom to focus on patient care.

VIPLabTech

Informatics Solutions

Is it time to change the way you see your lab? Simplify data to unburden you from the disruptions, complexities and distractions that pull your focus away from patient care. See how network insights, open connectivity and quality management can drive the change your lab needs.